{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:09:19Z","timestamp":1791461359159,"version":"4.3.4"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL095590-05"],"award-info":[{"award-number":["HL095590-05"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL094706"],"award-info":[{"award-number":["HL094706"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Russo Family Charitable Foundation Trust"},{"name":"Eshe Foundation"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.steroids.2014.04.005","type":"journal-article","created":{"date-parts":[[2014,4,21]],"date-time":"2014-04-21T11:45:13Z","timestamp":1398080713000},"page":"38-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"special_numbering":"C","title":["Mineralocorticoid receptors in immune cells: Emerging role in cardiovascular disease"],"prefix":"10.1016","volume":"91","author":[{"given":"Nicholas C.","family":"Bene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Alcaide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry H.","family":"Wortis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris Z.","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2014.04.005_b0005","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ccl.2010.04.001","article-title":"The role of aldosteronism in causing obesity-related cardiovascular risk","volume":"28","author":"Calhoun","year":"2010","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.steroids.2014.04.005_b0010","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/eurheartj\/ehr176","article-title":"Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure","volume":"33","author":"Ivanes","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.steroids.2014.04.005_b0015","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.steroids.2014.04.005_b0020","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.steroids.2014.04.005_b0025","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.steroids.2014.04.005_b0030","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/01.CIR.0000091405.00772.6E","article-title":"Effects of eplerenone, enalapril, and eplerenone\/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study","volume":"108","author":"Pitt","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.steroids.2014.04.005_b0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.steroids.2014.04.005_b0040","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1096\/fj.06-7970com","article-title":"Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis","volume":"21","author":"Caprio","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.steroids.2014.04.005_b0045","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1161\/CIRCRESAHA.108.174235","article-title":"Functional mineralocorticoid receptors in human vascular endothelial cells regulate ICAM-1 expression and promote leukocyte adhesion","volume":"102","author":"Caprio","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.steroids.2014.04.005_b0050","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/01.RES.0000159937.05502.d1","article-title":"Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells","volume":"96","author":"Jaffe","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.steroids.2014.04.005_b0055","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/01.RES.71.3.503","article-title":"Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor","volume":"71","author":"Lombes","year":"1992","journal-title":"Circ Res"},{"key":"10.1016\/j.steroids.2014.04.005_b0060","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.mce.2011.06.014","article-title":"Mineralocorticoid receptors in vascular function and disease","volume":"350","author":"McCurley","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.steroids.2014.04.005_b0065","doi-asserted-by":"crossref","unstructured":"McCurley A, McGraw AP, Pruthi D, Jaffe IZ. Smooth muscle cell mineralocorticoid receptors: role in vascular function and contribution to cardiovascular disease. Pflugers Archiv 2013;465:1661\u20131670 [Epub ahead of print].","DOI":"10.1007\/s00424-013-1282-4"},{"key":"10.1016\/j.steroids.2014.04.005_b0070","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s11883-013-0340-x","article-title":"Mineralocorticoid receptors in vascular disease: connecting molecular pathways to clinical implications","volume":"15","author":"McGraw","year":"2013","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.steroids.2014.04.005_b0075","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0039-128X(99)00087-2","article-title":"Mineralocorticoid action","volume":"65","author":"Rogerson","year":"2000","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2014.04.005_b0080","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/01.HYP.0000193502.77417.17","article-title":"Mechanisms of mineralocorticoid action","volume":"46","author":"Fuller","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.steroids.2014.04.005_b0085","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1046\/j.1523-1755.2000.00976.x","article-title":"Mineralocorticoid selectivity: molecular and cellular aspects","volume":"57","author":"Farman","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.steroids.2014.04.005_b0090","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1126\/science.2845584","article-title":"Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated","volume":"242","author":"Funder","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.steroids.2014.04.005_b0095","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/hc3001.093502","article-title":"Effects of ramipril on coronary events in high-risk persons: results of the Heart Outcomes Prevention Evaluation Study","volume":"104","author":"Dagenais","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.steroids.2014.04.005_b0100","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction, results of the survival and ventricular enlargement trial. The SAVE Investigators","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.steroids.2014.04.005_b0105","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1210\/me.2004-0529","article-title":"A Nuclear Receptor Atlas: macrophage activation","volume":"19","author":"Barish","year":"2005","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.steroids.2014.04.005_b0110","doi-asserted-by":"crossref","first-page":"7605","DOI":"10.4049\/jimmunol.176.12.7605","article-title":"Local amplification of glucocorticoids by 11 beta-hydroxysteroid dehydrogenase type 1 promotes macrophage phagocytosis of apoptotic leukocytes","volume":"176","author":"Gilmour","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.steroids.2014.04.005_b0115","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1172\/JCI41080","article-title":"Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice","volume":"120","author":"Usher","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.steroids.2014.04.005_b0120","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nri978","article-title":"Alternative activation of macrophages","volume":"3","author":"Gordon","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.steroids.2014.04.005_b0125","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/1742-2094-9-260","article-title":"Mineralocorticoid and glucocorticoid receptors differentially regulate NF-kappaB activity and pro-inflammatory cytokine production in murine BV-2 microglial cells","volume":"9","author":"Chantong","year":"2002","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.steroids.2014.04.005_b0130","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1126\/science.1071914","article-title":"The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation","volume":"298","author":"Hoffmann","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.steroids.2014.04.005_b0135","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/00005344-200306000-00019","article-title":"Effect of eplerenone, a selective aldosterone blocker, on blood pressure, serum and macrophage oxidative stress, and atherosclerosis in apolipoprotein E-deficient mice","volume":"41","author":"Keidar","year":"2003","journal-title":"J Cardiovasc Pharm"},{"key":"10.1016\/j.steroids.2014.04.005_b0140","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.coi.2006.03.017","article-title":"Expanding the effector CD4 T-cell repertoire: the Th17 lineage","volume":"18","author":"Harrington","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.steroids.2014.04.005_b0145","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1530\/acta.0.1180479","article-title":"Parallel determination of mineralocorticoid and glucocorticoid receptors in T- and B-lymphocytes of human spleen","volume":"118","author":"Armanini","year":"1988","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.steroids.2014.04.005_b0150","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4049\/jimmunol.0802886","article-title":"Aldosterone promotes autoimmune damage by enhancing Th17-mediated immunity","volume":"184","author":"Herrada","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.steroids.2014.04.005_b0155","doi-asserted-by":"crossref","first-page":"R208","DOI":"10.1152\/ajpregu.90521.2008","article-title":"Regulation of T-cell function by endogenously produced angiotensin II","volume":"296","author":"Hoch","year":"2009","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.steroids.2014.04.005_b0160","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1161\/HYPERTENSIONAHA.110.162941","article-title":"T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury","volume":"57","author":"Barhoumi","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.steroids.2014.04.005_b0165","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1084\/jem.20070657","article-title":"Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction","volume":"204","author":"Guzik","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.steroids.2014.04.005_b0170","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1172\/JCI7451","article-title":"Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway","volume":"104","author":"Nataraj","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.steroids.2014.04.005_b0175","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1161\/HYPERTENSIONAHA.113.02883","article-title":"Spironolactone decreases DOCA-salt-induced organ damage by blocking the activation of T helper 17 and the downregulation of regulatory T lymphocytes","volume":"63","author":"Amador","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.steroids.2014.04.005_b0180","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/nm.2891","article-title":"Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors","volume":"18","author":"McCurley","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.steroids.2014.04.005_b0185","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1096\/fj.09-147926","article-title":"The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure","volume":"24","author":"Nguyen Dinh","year":"2010","journal-title":"FASEB J"},{"key":"10.1016\/j.steroids.2014.04.005_b0190","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1161\/CIRCULATIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research","volume":"117","author":"Calhoun","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.steroids.2014.04.005_b0195","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1210\/jc.2003-032149","article-title":"Distinguishing the antihypertensive and electrolyte effects of eplerenone","volume":"89","author":"Levy","year":"2004","journal-title":"J Clin Endocr Metab"},{"key":"10.1016\/j.steroids.2014.04.005_b0200","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.coph.2010.01.006","article-title":"Role of the adaptive immune system in hypertension","volume":"10","author":"Harrison","year":"2010","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.steroids.2014.04.005_b0205","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1161\/HYPERTENSIONAHA.110.163576","article-title":"Inflammation, immunity, and hypertension","volume":"57","author":"Harrison","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.steroids.2014.04.005_b0210","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.cjca.2012.06.009","article-title":"The immune system: role in hypertension","volume":"29","author":"Schiffrin","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.steroids.2014.04.005_b0215","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1161\/CIRCRESAHA.110.217299","article-title":"Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension","volume":"107","author":"Marvar","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.steroids.2014.04.005_b0220","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.109.145094","article-title":"Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction","volume":"55","author":"Madhur","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.steroids.2014.04.005_b0225","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/HYPERTENSIONAHA.111.181123","article-title":"T regulatory lymphocytes prevent aldosterone-induced vascular injury","volume":"59","author":"Kasal","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.steroids.2014.04.005_b0230","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1161\/CIRCULATIONAHA.108.832782","article-title":"Regulatory T cells ameliorate angiotensin II-induced cardiac damage","volume":"119","author":"Kvakan","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.steroids.2014.04.005_b0235","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF00199863","article-title":"Systemic administration of autologous, alloactivated helper-enriched lymphocytes to patients with metastatic melanoma of the lung. A phase I study","volume":"21","author":"Balsari","year":"1986","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.steroids.2014.04.005_b0240","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/01.aids.0000171410.76607.f8","article-title":"Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003","volume":"19","author":"Seaberg","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.steroids.2014.04.005_b0245","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature11868","article-title":"Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells","volume":"496","author":"Kleinewietfeld","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.steroids.2014.04.005_b0250","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nature11984","article-title":"Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1","volume":"496","author":"Wu","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.steroids.2014.04.005_b0255","first-page":"834","article-title":"Cross-talk between aldosterone and angiotensin signaling in vascular smooth muscle cells","volume":"76","author":"Rautureau","year":"2011","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2014.04.005_b0260","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1161\/HYPERTENSIONAHA.109.131110","article-title":"Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone\/salt-induced cardiac fibrosis and increased blood pressure","volume":"54","author":"Rickard","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.steroids.2014.04.005_b0265","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1210\/en.2011-2098","article-title":"Macrophage mineralocorticoid receptor signaling plays a key role in aldosterone-independent cardiac fibrosis","volume":"153","author":"Bienvenu","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2014.04.005_b0270","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10741-010-9161-y","article-title":"The role of inflammatory and fibrogenic pathways in heart failure associated with aging","volume":"15","author":"Chen","year":"2010","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.steroids.2014.04.005_b0275","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.tcm.2010.02.005","article-title":"Mechanisms of cardiac fibrosis in inflammatory heart disease","volume":"19","author":"Kania","year":"2009","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.steroids.2014.04.005_b0280","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1524-6175.2007.06626.x","article-title":"Mechanisms of cardiac fibrosis in hypertension","volume":"9","author":"Diez","year":"2007","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.steroids.2014.04.005_b0285","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.hfc.2011.08.011","article-title":"Aging-associated cardiovascular changes and their relationship to heart failure","volume":"8","author":"Strait","year":"2012","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.steroids.2014.04.005_b0290","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1742-7843.2011.00760.x","article-title":"Immune modulation of resistance artery remodelling","volume":"110","author":"Schiffrin","year":"2012","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.steroids.2014.04.005_b0295","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.yexmp.2011.04.003","article-title":"Lentivirus mediated IL-17R blockade improves diastolic cardiac function in spontaneously hypertensive rats","volume":"91","author":"Liu","year":"2011","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.steroids.2014.04.005_b0300","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.yexmp.2009.06.001","article-title":"IL-17 induces myocardial fibrosis and enhances RANKL\/OPG and MMP\/TIMP signaling in isoproterenol-induced heart failure","volume":"87","author":"Feng","year":"2009","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.steroids.2014.04.005_b0305","doi-asserted-by":"crossref","first-page":"H3356","DOI":"10.1152\/ajpheart.00928.2007","article-title":"IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1\/2-dependent C\/EBP-beta, NF-kappaB, and AP-1 activation","volume":"293","author":"Cortez","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.steroids.2014.04.005_b0310","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahlof","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.steroids.2014.04.005_b0315","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"The SOLVD Investigators","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.steroids.2014.04.005_b0320","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1161\/01.CIR.0000127949.05756.9D","article-title":"Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone","volume":"109","author":"Keidar","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.steroids.2014.04.005_b0325","doi-asserted-by":"crossref","first-page":"e000018","DOI":"10.1161\/JAHA.112.000018","article-title":"Aldosterone increases early atherosclerosis and promotes plaque inflammation through a placental growth factor-dependent mechanism","volume":"2","author":"McGraw","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.steroids.2014.04.005_b0330","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1210\/en.2010-0925","article-title":"11Beta-hydroxysteroid dehydrogenase type 2 deficiency accelerates atherogenesis and causes proinflammatory changes in the endothelium in apoe\u2212\/\u2212 mice","volume":"152","author":"Deuchar","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2014.04.005_b0335","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1161\/ATVBAHA.108.174128","article-title":"Critical role of macrophages in glucocorticoid driven vascular calcification in a mouse-model of atherosclerosis","volume":"28","author":"Preusch","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.steroids.2014.04.005_b0340","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1161\/STROKEAHA.110.598441","article-title":"Myeloid-specific deletion of the mineralocorticoid receptor reduces infarct volume and alters inflammation during cerebral ischemia","volume":"42","author":"Frieler","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.steroids.2014.04.005_b0345","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/01.ATV.6.2.131","article-title":"Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque","volume":"6","author":"Jonasson","year":"1986","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.steroids.2014.04.005_b0350","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1172\/JCI63108","article-title":"Adaptive immunity in atherogenesis: new insights and therapeutic approaches","volume":"123","author":"Lichtman","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.steroids.2014.04.005_b0355","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1172\/JCI119465","article-title":"IFN-gamma potentiates atherosclerosis in ApoE knock-out mice","volume":"99","author":"Gupta","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.steroids.2014.04.005_b0360","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1073\/pnas.0409015102","article-title":"T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses","volume":"102","author":"Buono","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.steroids.2014.04.005_b0365","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1073\/pnas.92.9.3893","article-title":"T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein","volume":"92","author":"Stemme","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.steroids.2014.04.005_b0370","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.4049\/jimmunol.1003947","article-title":"Foxp3+-inducible regulatory T cells suppress endothelial activation and leukocyte recruitment","volume":"187","author":"Maganto-Garcia","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.steroids.2014.04.005_b0375","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1161\/01.CIR.0000133316.92316.81","article-title":"Widespread myocardial inflammation and infarct-related artery patency","volume":"110","author":"Abbate","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.steroids.2014.04.005_b0380","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1161\/CIRCULATIONAHA.111.044164","article-title":"Activation of CD4+ T lymphocytes improves wound healing and survival after experimental myocardial infarction in mice","volume":"125","author":"Hofmann","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.steroids.2014.04.005_b0385","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1161\/ATVBAHA.112.249235","article-title":"Refining the role of B cells in atherosclerosis","volume":"32","author":"Perry","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.steroids.2014.04.005_b0390","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tcm.2012.06.011","article-title":"Protective role of natural IgM-producing B1a cells in atherosclerosis","volume":"22","author":"Kyaw","year":"2012","journal-title":"Trends Cardiovasc Med"}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X14000762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X14000762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T15:13:31Z","timestamp":1565363611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X14000762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":78,"alternative-id":["S0039128X14000762"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2014.04.005","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mineralocorticoid receptors in immune cells: Emerging role in cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2014.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}